We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Mediclinic International Plc | LSE:MDC | London | Ordinary Share | GB00B8HX8Z88 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 501.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMMDC
RNS Number : 7064X
Mediclinic International PLC
23 February 2017
Mediclinic International plc
(Incorporated in England and Wales)
Company Number 8338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
23 February 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES ------------------------------------------------------------------------------------------ 1. Identity of the issuer or Mediclinic International the underlying issuer plc of existing shares to which voting rights are attached: ----------------------------------------------------------- ----------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------------------------------ An acquisition or disposal of voting rights x ------------------------------------------------------------ ---------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------ ---------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------ ---------------------------- An event changing the breakdown of voting rights ------------------------------------------------------------ ---------------------------- Other (please specify): ---------------------------------------------------------- ---------------------------- 3. Full name of person(s) Coronation Asset Management subject to the (Pty) Ltd notification obligation: ----------------------------------------------------------- ----------------------------- 4. Full name of shareholder(s) N/A (if different from 3.): ----------------------------------------------------------- ----------------------------- 5. Date of the transaction 23 February 2017 and date on which the threshold is crossed or reached: ----------------------------------------------------------- ----------------------------- 6. Date on which issuer 23 February 2017 notified: ----------------------------------------------------------- ----------------------------- 7. Threshold(s) that is/are crossed or reached: 3% ----------------------------------------------------------- ----------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- --------------------------------- -------------------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights Shares Voting rights Rights ------------- --------------- ---------------- -------------- ------------------------ -------------------------- Direct Direct Indirect Direct Indirect ------------- ----------- ------------ -------------- ---------- ------------ ------------ ------------ 21 606 21 606 22 794 22 794 GB00B8HX8Z88 841 841 561 561 3.09% --------------- ---------------- -------------- ---------- ------------ ------------ ------------ B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument Period may be acquired if the instrument is exercised/ converted. ----------------- ------------- -------------------------------- -------------------------- ---------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights instrument period refers to --------------- ------------- -------------- ---------------- -------------------------- ------------------------ Nominal Delta --------------- ------------- -------------- ---------------- -------------------------- ------------ ---------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights -------------------------------------------------- ------------------------------------------------------------------ 22 794 561 3.09% -------------------------------------------------- ------------------------------------------------------------------ 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: ---------------------------------------------------------------------------------------------------------------------- Proxy Voting: ---------------------------------------------------------------------------------------------------------------------- 10. Name of the proxy holder: Coronation Asset Management (Pty) Ltd ---------------------------------------------------------------------------- ---------------------------------------- 11. Number of voting rights proxy holder will cease to hold: ---------------------------------------------------------------------------- ---------------------------------------- 12. Date on which proxy holder will cease to hold voting rights: ---------------------------------------------------------------------------- ---------------------------------------- 13. Additional information: -------------------------------------------------- ------------------------------------------------------------------ 14. Contact name: Jamie Rowland -------------------------------------------------- ------------------------------------------------------------------ 15. Contact telephone number: +27 21 680 2000 -------------------------------------------------- ------------------------------------------------------------------
Mediclinic's primary listing is on the Main Market of the LSE, with secondary listings on the JSE in South Africa and on the NSX in Namibia.
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
For further information please contact:
Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
Capita Company Secretarial Services Limited
Victoria Dalby
+44 (0)207 954 9600
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLBDGDDSUDBGRX
(END) Dow Jones Newswires
February 23, 2017 09:00 ET (14:00 GMT)
1 Year Mediclinic Chart |
1 Month Mediclinic Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions